Patents by Inventor John Whatley

John Whatley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
    Patent number: 8658194
    Abstract: A segmented polyurethane and an amphiphilic random or block copolymer are disclosed. The segmented polyurethane and the amphiphilic random or block copolymer can be used for fabricating a coating for an implantable medical device such as a stent.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: February 25, 2014
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Thierry Glauser, Connie S. Kwok, Charles D. Claude, Eugene T. Michal, Yiwen Tang, Irina Astafieva, John Whatley, Stephen D. Pacetti, Ashok Shah
  • Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
    Patent number: 8309112
    Abstract: A segmented polyurethane and an amphiphilic random or block copolymer are disclosed. The segmented polyurethane and the amphiphilic random or block copolymer can be used for fabricating a coating for an implantable medical device such as a stent.
    Type: Grant
    Filed: December 24, 2003
    Date of Patent: November 13, 2012
    Assignee: Advanced Cardiovascular Systems, Inc.
    Inventors: Thierry Glauser, Connie S. Kwok, Charles D. Claude, Eugene T. Michal, Yiwen Tang, Irina Astafieva, John Whatley, Stephen D. Pacetti, Ashok Shah
  • COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING HYDROPHILIC SUBSTANCES AND METHODS FOR FABRICATING THE SAME
    Publication number: 20110033517
    Abstract: A segmented polyurethane and an amphiphilic random or block copolymer are disclosed. The segmented polyurethane and the amphiphilic random or block copolymer can be used for fabricating a coating for an implantable medical device such as a stent.
    Type: Application
    Filed: October 21, 2010
    Publication date: February 10, 2011
    Inventors: Thierry Glauser, Connie S. Kwok, Charles D. Claude, Eugene T. Michal, Yiwen Tang, Irina Astafieva, John Whatley, Stephen D. Pacetti, Ashok Shah
  • Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
    Publication number: 20050232899
    Abstract: Stable aqueous formulations which are free of products derived from human or animal origin and which maintain high biological activity and high chemical and physical stability of alpha-type interferon, and proteins in general, for an extended period of time. Methods of producing stable aerosol formulations of the same for delivery to the lungs are also provided, as well as systems and methods of delivering the formulations to the lungs for systemic absorption.
    Type: Application
    Filed: August 25, 2004
    Publication date: October 20, 2005
    Inventors: Gul Balwani, Brooks Boyd, John Whatley
  • Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
    Publication number: 20050147647
    Abstract: A segmented polyurethane and an amphiphilic random or block copolymer are disclosed. The segmented polyurethane and the amphiphilic random or block copolymer can be used for fabricating a coating for an implantable medical device such as a stent.
    Type: Application
    Filed: December 24, 2003
    Publication date: July 7, 2005
    Inventors: Thierry Glauser, Connie Kwok, Charles Claude, Eugene Michal, Yiwen Tang, Irina Astafieva, Stephen Pacetti, John Whatley, Ashok Shah
  • Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
    Patent number: 6830744
    Abstract: Stable aqueous formulations which are free of products derived from human or animal origin and which maintain high biological activity and high chemical and physical stability of alpha-type interferon for an extended period of time. Methods of producing stable aerosol formulations of the same for delivery to the lungs are also provided, as well as systems and methods of delivering the formulations to the lungs for systemic absorption.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: December 14, 2004
    Assignee: Aradigm Corporation
    Inventors: Gul Balwani, Brooks Boyd, John Whatley
  • Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
    Publication number: 20030223936
    Abstract: Stable aqueous formulations which are free of products derived from human or animal origin and which maintain high biological activity and high chemical and physical stability of alpha-type interferon for an extended period of time. Methods of producing stable aerosol formulations of the same for delivery to the lungs are also provided, as well as systems and methods of delivering the formulations to the lungs for systemic absorption.
    Type: Application
    Filed: May 31, 2002
    Publication date: December 4, 2003
    Inventors: Gul Balwani, Brooks Boyd, John Whatley